Effect of liver metastasis on the efficacy of immune checkpoint inhibitors in cancer patients: a systemic review and meta-analysis
BW Tian, CL Han, HC Wang, LJ Yan, ZN Ding… - Clinical & Experimental …, 2023 - Springer
Liver metastasis is a frequent phenomenon in advanced tumor disease. Immune checkpoint
inhibitors (ICIs) are a new class of therapeutics that can improve the prognosis of cancer …
inhibitors (ICIs) are a new class of therapeutics that can improve the prognosis of cancer …
Immunotherapy targeting PD‑1/PD‑L1: A potential approach for the treatment of cancer bone metastases
T Hiraga - International Journal of Oncology, 2024 - spandidos-publications.com
Immune checkpoint molecules, such as programmed cell death 1 (PD‑1) and programmed
cell death ligand 1 (PD‑L1), have a critical role in regulating immune responses, including in …
cell death ligand 1 (PD‑L1), have a critical role in regulating immune responses, including in …
p63 orchestrates serine and one carbon metabolism enzymes expression in head and neck cancer
Background Head and neck squamous cell carcinoma (HNSCC) is characterized by high
proliferation and limited differentiation. The altered expression of the p53 family members …
proliferation and limited differentiation. The altered expression of the p53 family members …
Serine and one-carbon metabolism sustain non-melanoma skin cancer progression
A Cappello, A Zuccotti, M Mancini, G Tosetti… - Cell Death …, 2023 - nature.com
Non-melanoma skin cancer (NMSC) is a tumor that arises from human keratinocytes,
showing abnormal control of cell proliferation and aberrant stratification. Cutaneous basal …
showing abnormal control of cell proliferation and aberrant stratification. Cutaneous basal …
Genetically driven predisposition leads to an unusually genomic unstable renal cell carcinoma
Renal cell carcinoma originates from the lining of the proximal convoluted renal tubule and
represents the most common type of kidney cancer. Risk factors and comorbidities might be …
represents the most common type of kidney cancer. Risk factors and comorbidities might be …